Flecainide in CASQ2-mediated catecholaminergic polymorphic ventricular tachycardia: The gift that keeps on giving

被引：1
|
作者：
Gopinathannair, Rakesh [1 ]
机构：
[1] Univ Louisville, Div Cardiovasc Med, Sect Electrophysiol, Louisville, KY 40292 USA
来源：
HEART RHYTHM | 2013年 / 10卷 / 11期
关键词：
ARRHYTHMIAS; THERAPY;
D O I：
10.1016/j.hrthm.2013.08.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1676 / 1677
页数：2
相关论文
共 50 条
  • [1] CASQ2 mutations and catecholaminergic polymorphic ventricular tachycardia
    Chen, Peng-Sheng
    HEART RHYTHM, 2006, 3 (12) : 1510 - 1510
  • [2] Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia
    Biernacka, Elzbieta Katarzyna
    Hoffman, Piotr
    EUROPACE, 2011, 13 (01): : 129 - 130
  • [3] The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia
    Lieve, Krystien V. V.
    Wilde, Arthur A.
    van der Werf, Christian
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2016, 5 (01) : 45 - 49
  • [4] The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
    Li, Yukun
    Peng, Xiaodong
    Lin, Rong
    Wang, Xuesi
    Liu, Xinmeng
    Bai, Rong
    Ma, Changsheng
    Tang, Ribo
    Ruan, Yanfei
    Liu, Nian
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [5] Efficacy and safety of flecainide in catecholaminergic polymorphic ventricular tachycardia
    Wanguemert Perez, F.
    Ruiz Hernandez, P.
    Berne, P.
    Campuzano Larrea, O.
    Bosch Calero, C.
    Perez, G. J.
    Perez Rodriguez, C.
    Brugada, J.
    Brugada, R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 831 - 831
  • [6] Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia
    Khoury, Asaad
    Marai, Ibrahim
    Suleiman, Mahmoud
    Blich, Miry
    Lorber, Avraham
    Gepstein, Lior
    Boulos, Monther
    HEART RHYTHM, 2013, 10 (11) : 1671 - 1675
  • [7] CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
    Li, Qirui
    Guo, Ruolan
    Gao, Lu
    Cui, Lang
    Zhao, Zhihui
    Yu, Xia
    Yuan, Yue
    Xu, Xiwei
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (11):
  • [8] The Phenotype of a CASQ2 Mutation in a Saudi Family with Catecholaminergic Polymorphic Ventricular Tachycardia
    Al-Hassnan, Zuhair N.
    Tulbah, Sahar
    Al-Manea, Waleed
    Al-Fayyadh, Majid
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (05): : e140 - e142
  • [9] Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
    Watanabe, Hiroshi
    Chopra, Nagesh
    Laver, Derek
    Hwang, Hyun Seok
    Davies, Sean S.
    Roach, Daniel E.
    Duff, Henry J.
    Roden, Dan M.
    Wilde, Arthur A. M.
    Knollmann, Bjoern C.
    NATURE MEDICINE, 2009, 15 (04) : 380 - 383
  • [10] Flecainide monotherapy for catecholaminergic polymorphic ventricular tachycardia: Perspectives and limitations
    Napolitano, Carlo
    HEART RHYTHM, 2016, 13 (02) : 614 - 615
12345